Listen

Add to my selection

VEKLURY

Medicine - Posted on Jan 13 2023

Active substance (DCI)

remdesivir

history (2)

1/4/23

VEKLURY (remdésivir) - COVID-19

Key points Approval of reimbursement subject to susceptibility of the SARS-CoV-2 strain to remdesivir, in recommended cohort...

CAV :
54321

icône flèche
9/16/20

VEKLURY

First assessment Application for reimbursement withdrawn by the pharmaceutical company Favourable opinion for reimbursement ...

CAV :
54321

icône flèche

Technical information

ATC code

J05AB16

Manufacturer

GILEAD SCIENCES

Presentation

VEKLURY 100 mg powder for concentrate for solution for infusion and concentrate for solution for infusion

All our publications